氨酸莫菲蒂尔对包括SARS-CoV-2在内的冠状病毒具有广泛的抗病毒活性
Mengyuan Wu1, Kun Wang1, Huiqiang Wang1
1CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Virology journal
|March 4, 2025
概括
菌酸莫菲提尔 (MMF) 和菌酸 (MPA) 显示出对冠状病毒的广泛抗病毒活性,包括SARS-CoV-2变种. 这些药物通过阻断 purin 合成来抑制病毒复制,显示出临床使用的潜力.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 由于SARS-CoV-2变种,持续开发抗冠状病毒药物至关重要.
- 菌酸莫菲蒂尔 (MMF) 和菌酸 (MPA) 显示出潜在的抗病毒性质.
- 关于它们的泛冠状病毒活动和机制的研究有限.
研究的目的:
- 系统评估货币市场基金和货币管理机构的抗冠状病毒活动.
- 阐明它们抗病毒作用背后的机制.
- 评估它们对抗SARS-CoV-2及其变种的潜力.
主要方法:
- 通过qRT-PCR,西式涂抹和免疫光评估的抗病毒作用.
- 使用细胞热转移试验和西式涂抹评估的因诺辛-5'-单酸脱酶 (IMPDH) 抑制.
主要成果:
- MMF和MPA对HCoV-229E,HCoV-OC43和SARS-CoV-2菌株/变种进行了广泛的抑制.
- 通过IMPDH,MMF通过抑制氨酸合成来向早期的病毒感染阶段.
- 货币货币基金的抗病毒作用是瓜诺辛可以逆转的;与其他抗病毒药物观察到的协同效应.
结论:
- 货币货币基金和MPA通过IMPDH抑制具有广泛的抗冠状病毒活性.
- 货币货币基金与其他药物的协同作用潜力凸显了其临床适用性.
- 这些发现支持MMF和MPA作为冠状病毒治疗的候选者.
相关概念视频
Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
695
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
695
Subviral Agents
933
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
933
Cytomegalovirus Disease
102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119


